REGN-COV2 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "REGN-COV2" in Korean language version.

refsWebsite

Global rank Korean rank

4^th place

4^th place

49^th place

110^th place

low place

low place

20^th place

66^th place

1clinicaltrials.gov

5,225^th place

4,327^th place

18^th place

27^th place

2^nd place

3^rd place

447^th place

433^rd place

bbc.com

Morelle, Rebecca (2020년 9월 14일). “Antibody treatment to be given to Covid patients”. 《BBC News Online》. 2020년 9월 14일에 확인함.

clinicaltrials.gov

“Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19”. 《ClinicalTrials》. 2020년 9월 3일. 2020년 9월 14일에 확인함.

doi.org

dx.doi.org

Baum A, Fulton BO, Wloga E, Copin R, Pascal KE, Russo V, 외. (August 2020). “Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies”. 《Science》 369 (6506): 1014–1018. Bibcode:2020Sci...369.1014B. doi:10.1126/science.abd0831. PMC 7299283. PMID 32540904.

fda.gov

“Fact Sheet For Health Care Providers Emergency Use Authorization (EUA) Of Casirivimab And Imdevimab” (PDF). 《U.S. Food and Drug Administration (FDA)》. June 2021.

harvard.edu

adsabs.harvard.edu

Baum A, Fulton BO, Wloga E, Copin R, Pascal KE, Russo V, 외. (August 2020). “Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies”. 《Science》 369 (6506): 1014–1018. Bibcode:2020Sci...369.1014B. doi:10.1126/science.abd0831. PMC 7299283. PMID 32540904.

nih.gov

dailymed.nlm.nih.gov

“Casirivimab injection, solution, concentrate Imdevimab injection, solution, concentrate REGEN-COV- casirivimab and imdevimab kit”. 《DailyMed》. 2021년 3월 18일에 확인함.

ncbi.nlm.nih.gov

Baum A, Fulton BO, Wloga E, Copin R, Pascal KE, Russo V, 외. (August 2020). “Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies”. 《Science》 369 (6506): 1014–1018. Bibcode:2020Sci...369.1014B. doi:10.1126/science.abd0831. PMC 7299283. PMID 32540904.

regeneron.com

“Regeneron's COVID-19 Response Efforts”. 《Regeneron Pharmaceuticals》. 2020년 9월 14일에 확인함.

reuters.com

Kelland, Kate (2020년 9월 14일). “Regeneron's antibody drug added to UK Recovery trial of COVID treatments”. 《Reuters》. 2020년 9월 14일에 확인함.